- In this commentary, the author discusses management strategies for children with sickle cell anemia (SCA) who regularly require blood transfusions while anticipating a potential blood shortage in the setting of the COVID-19 pandemic.
- The author's primary recommendation is to consider initiation of low-dose hydroxyurea (10 mg/kg/day) for all children with SCA who regularly receive blood transfusions for either primary or secondary prevention of stroke.
No comments:
Post a Comment